Skip to main content
. Author manuscript; available in PMC: 2013 Aug 22.
Published in final edited form as: Pharmaceuticals (Basel). 2013 Mar 25;6(4):440–468. doi: 10.3390/ph6040440

Figure 1.

Figure 1

siRNA design overview. siRNA therapeutic design should, in the short term, begin by addressing diseases with unmet therapeutic need that are treatable by siRNA-based therapeutics. While initial siRNA and delivery vehicle design begins with some design heuristics, as discussed in the following sections, a completely optimized therapeutic will require concomitant, parallel development of each of the constituents followed by experimental validation of the optimized therapeutic.